Rate Video

BTOG 2020 | UK excels at molecular testing for lung cancer

Riyaz Shah • 29 Jan 2020

Lung Cancer Non-Small Cell Lung Cancer

Speaking from the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK, Riyaz Shah, FRCP, PhD, The Royal Marsden Hospital, London, UK, discusses the practice of molecular testing for patients with lung cancer in the UK.

Targeted therapy in NSCLC at ASCO 2020

Riyaz Shah • 19 Jun 2020

Impact and learnings from the COVID-19 pandemic

Riyaz Shah • 16 Jun 2020

Management of frontline ALK+ NSCLC: brigatinib vs. alectinib

Riyaz Shah • 29 Jan 2020

Radiotherapy: do WBRT/PCI still have a role in NSCLC/SCLC?

Riyaz Shah • 29 Jan 2020

Related Videos

Updates on MRx0518 + pembro in patients with resistance to therapy

Alex Stevenson • 27 Nov 2020

STIMULI trial update at ESMO 2020

Dirk De Ruysscher • 16 Nov 2020

Exciting updates at the Gathering around Cancer meeting

Jarushka Naidoo • 4 Nov 2020

Osimertinib for EGFR-mutant lung cancer

Jarushka Naidoo • 4 Nov 2020